Akso Health Group
AHG
11 hedge funds and large institutions have $420K invested in Akso Health Group in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
83% more funds holding
Funds holding: 6 → 11 (+5)
0.01% more ownership
Funds ownership: 0.03% → 0.03% (+0.01%)
19% less capital invested
Capital invested by funds: $517K → $420K (-$97.8K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$82.9K |
| 2 |
Jane Street
New York
|
+$18.2K |
| 3 |
BlackRock
New York
|
+$18.1K |
| 4 |
SP
SmartHarvest Portfolios
Poulsbo,
Washington
|
+$16.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$8.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$49.5K |
AHG Hedge Fund Activity: Q2 2026 in Review
11 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q2 2026, worth a combined $420K — down 19% from $517K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AHG positions and 0 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $82.9K. The largest seller was Renaissance Technologies, cutting an estimated $49.5K.
- 11 institutional investors held Akso Health Group (AHG) as of Q2 2026, up from 6 in Q1 2026.
- Funds reported $420K of Akso Health Group stock for Q2 2026, down 19% quarter-over-quarter.
- 5 funds opened new Akso Health Group positions in Q2 2026 and 0 closed out, a net change of +5 holders.
- The largest Akso Health Group buyer in Q2 2026 was Citadel Advisors, an estimated $82.9K added.
- The largest Akso Health Group seller in Q2 2026 was Renaissance Technologies, an estimated $49.5K sold.
Based on aggregated 13F filings for Q2 2026.